Analyzing Cellebrite DI (NASDAQ:CLBT) & Similarweb (NYSE:SMWB)

Similarweb (NYSE:SMWB – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Similarweb and Cellebrite DI, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Similarweb 1 5 4 0 2.30
Cellebrite DI 1 0 4 0 2.60

Similarweb currently has a consensus target price of $10.00, suggesting a potential upside of 26.58%. Cellebrite DI has a consensus target price of $14.75, suggesting a potential upside of 30.30%. Given Cellebrite DI’s stronger consensus rating and higher probable upside, analysts plainly believe Cellebrite DI is more favorable than Similarweb.

Earnings & Valuation

This table compares Similarweb and Cellebrite DI”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Similarweb $282.60 million 2.45 -$32.94 million ($0.16) -49.38
Cellebrite DI $475.67 million 5.94 $78.33 million $0.24 47.17

Cellebrite DI has higher revenue and earnings than Similarweb. Similarweb is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Similarweb has a beta of 1.36, suggesting that its stock price is 36% more volatile than the S&P 500. Comparatively, Cellebrite DI has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

Institutional & Insider Ownership

57.6% of Similarweb shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 62.4% of Similarweb shares are held by company insiders. Comparatively, 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Similarweb and Cellebrite DI’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Similarweb -4.56% -2.25% -0.21%
Cellebrite DI 12.14% 16.91% 9.03%

Summary

Cellebrite DI beats Similarweb on 10 of the 13 factors compared between the two stocks.

About Similarweb

(Get Free Report)

Similarweb Ltd. is a digital intelligence company that helps businesses understand online activity and competition. Its platform collects and analyzes data about website visits, mobile app usage, search behavior and other digital interactions, then presents the information through analytics and benchmarking tools. Similarweb’s products support market research, competitive analysis, digital marketing, sales prospecting and investment research. Customers can use the platform to assess digital audiences and trends, compare performance with competitors, and identify opportunities across online markets.

About Cellebrite DI

(Get Free Report)

Cellebrite DI Ltd. develops digital intelligence software and services that help organizations access, collect, preserve and analyze digital evidence. Its tools are used to investigate information from mobile devices, computers, cloud sources and other digital systems. The company’s offerings include its UFED platform for extracting data from digital devices, Physical Analyzer for examining and interpreting evidence, and analytics and case-management tools such as Pathfinder and Guardian. Customers include law enforcement, public safety, intelligence and defense agencies, as well as organizations in the private sector.

Receive News & Ratings for Similarweb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Similarweb and related companies with MarketBeat.com's FREE daily email newsletter.